WHO WE ARE

Few experts penetrate the phytochemical and pharmacological complexity of the cannabis plant, its preparations and cannabinoids. For more than 10 years we have been dealing with aspects of pharmaceutical quality, isolation of THC, CBD and rare cannabinoids, as well as questions of genetics and plant biotechnology.
CEO Christian Kayser
Gesellschafter
Partner Dr. Oliver Kayser